조기 유방암에서 수술 전 유방초음파 및 유방 자기공명영상검사와 수술 후 병리학적 종양 크기에 대한 비교 연구
Analysis of Tumor Size between Imaging of Preoperative Ultrasound, MRI and Pathologic Measurements in Early Breast Carcinoma
1
조회
0
다운로드
1
인용
0
참고문헌
키워드
초록
Purpose: Preoperative tumor size is associated with clinical stage, treatment plan and even survival rate of patient. We investigated the accuracy of tumor size estimation between magnetic resonance imaging (MRI) and ultrasonography (US) findings, comparing these with pathologic tumor size in the diagnosis of early breast carcinoma. Methods: Between 2011 and 2016, 136 patients with early breast cancer were analyzed and their tumor size on US and MRI findings were compared with their pathologic tumor size retrospectively. The background parenchymal enhancement of MRI was categorized as minimal, mild, moderate, and extreme. The patients who underwent neoadjuvant chemotherapy, had positive resection margins, underwent excisional biopsy for cancer diagnosis, and had non-mass lesions on MRI scans, were excluded. Results: In all, 83.1% of the cases showed concordance between MRI findings and pathologic tumor size within 0.5cm. MRI overestimated the findings by 10.3% and underestimated them by 6.6%; 78.7% showed concordance between US findings and pathologic tumor size within 0.5cm. US overestimated the findings by 5.9% and underestimated them by 15.4%. The tumor size on MRI (r=0.87) showed a stronger correlation to the pathologic tumor size than that on US (r=0.64) in early breast cancer patients. US had a tendency to underestimate the tumor size. The degree of breast parenchyma did not affect the accuracy of the measurement of preoperative tumor size. Conclusion: MRI is relatively more accurate than US for assessing preoperative tumor size in breast cancer patients. US tends to underestimate tumor size.
Abstract
Purpose: Preoperative tumor size is associated with clinical stage, treatment plan and even survival rate of patient. We investigated the accuracy of tumor size estimation between magnetic resonance imaging (MRI) and ultrasonography (US) findings, comparing these with pathologic tumor size in the diagnosis of early breast carcinoma. Methods: Between 2011 and 2016, 136 patients with early breast cancer were analyzed and their tumor size on US and MRI findings were compared with their pathologic tumor size retrospectively. The background parenchymal enhancement of MRI was categorized as minimal, mild, moderate, and extreme. The patients who underwent neoadjuvant chemotherapy, had positive resection margins, underwent excisional biopsy for cancer diagnosis, and had non-mass lesions on MRI scans, were excluded. Results: In all, 83.1% of the cases showed concordance between MRI findings and pathologic tumor size within 0.5cm. MRI overestimated the findings by 10.3% and underestimated them by 6.6%; 78.7% showed concordance between US findings and pathologic tumor size within 0.5cm. US overestimated the findings by 5.9% and underestimated them by 15.4%. The tumor size on MRI (r=0.87) showed a stronger correlation to the pathologic tumor size than that on US (r=0.64) in early breast cancer patients. US had a tendency to underestimate the tumor size. The degree of breast parenchyma did not affect the accuracy of the measurement of preoperative tumor size. Conclusion: MRI is relatively more accurate than US for assessing preoperative tumor size in breast cancer patients. US tends to underestimate tumor size.
참고문헌 (28)
- 정규원, "Cancer Statistics in Korea: Incidence, Mortality, Survival, and Prevalence in 2015", Cancer Research and Treatment, 50(2), pp.303~316 (2018), 대한암학회
- Langlands AO, "Prognosis in breast cancer : the relevance of clinical staging", Clin Radiol, 29, pp.599~606 (1978)
- Langlands AO, "Should adjuvant chemotherapy be withheld from any patients with operable breast cancer? An analysis of strategies based on tumor size", Br Med J, 285, pp.680~682 (1982)
- Veronesi U, "Comparing radical mastectomy with quadrantectomy, axillary dissection and radiotherapy in patients with small cancers of the breast", N Engl J Med, 305, pp.6~11 (1981)
- Adair F, "Long-term follow-up of breast cancer patients : the 30-year report", Cancer, 33, pp.1145~1150 (1974)
- Pascual MR, "Factors associated with prognosis in human breast cancer: II. Multivariate stratification analysis", Neoplasma, 30, pp.485~492 (1983)
- Peterson AHG, "Influence and significance of certain prognostic factors on survival in breast cancer", Eur J Cancer Clin Oncol, 18, pp.937~943 (1982)
- Blamey RW, "Prognostic factors in breast cancer : the formation of a prognostic index", Clin Oncol, 5, pp.227~236 (1979)
- Rosen PP, "Predictors of recurrence in stage I(T1N0M0)breast carcinoma", Ann Surg, 193, pp.15~25 (1981)
- Wallgren A, "Prognostic factors in mammary carcinoma", Acta Radiol Ther Phys Biol, 15, pp.1~16 (1976)
- Atkinson EN, "Tumor volume, nodal status, and metastasis in breast cancer in women", J Natl Cancer Inst, 76, pp.171~178 (1986)
- Ellison-Loschmann L, "Age and ethnic differences in volumetric breast density in new zealand women : a cross-sectional study", PLoS One, 8, pp.e70217~ (2013)
- Harvey JA, "Quantitative assessment of mammographic breast density : relationship with breast cancer risk", Radiology, 230, pp.29~41 (2004)
- McCormack VA, "Ethnic variations in mammographic density : a British multiethnic longitudinal study", Am J Epidemiol, 168, pp.412~421 (2008)
- Ciatto S, "Breast density as a determinant of interval cancer at mammographic screening", Br J Cancer, 90, pp.393~396 (2004)
- 육지현, "Supplementary Screening Sonography in Mammographically Dense Breast: Pros and Cons", Korean Journal of Radiology, 11(6), pp.589~593 (2010), 대한영상의학회
- Winkler NS, "Breast density : clinical implications and assessment methods", Radiographics, 35, pp.316~324 (2015)
- Huay-Ben P, "The role of breast ultrasound in early cancer detection", J Med Ultrasound, 24, pp.138~141 (2016)
- Kuerer HM, "Clinical course of breast cancer patients with complete pathologic primary tumor and axillary lymph node response to doxorubicin-based neoadjuvant chemotherapy", J Clin Oncol, 17, pp.460~469 (1999)
- van der Hage JA, "Preoperative chemotherapy in primary operable breast cancer : results from the European organization for research and treatment of cancer trial 10902", J Clin Oncol, 19, pp.4224~4237 (2001)
- Do Youn Kim, "MRI of the Breast for the Detection and Assessment of the Size of Ductal Carcinoma in Situ", Korean Journal of Radiology, 8(1), pp.32~39 (2007), 대한영상의학회
- Gonzalez V, "Preoperative MRI of the breast(POMB)influences primary treatment in breast cancer : a prospective, randomized, multicenter study", World J Surg, 38, pp.1685~1693 (2014)
- Yang WT, "Sonographic, magnetic resonance imaging, and mammographic assessments of preoperative size of breast cancer", J Ultrasound Med, 16, pp.791~797 (1997)
- Cheung YC, "Preoperative magnetic resonance imaging evaluation for breast cancers after sonographically guided core-needle biopsy : a comparison study", Ann Surg Oncol, 11, pp.756~761 (2004)
- 노동영, "유방 종양 환자에서 수술 전 진단적 종양 크기와 수술 후 병리학적 종양 크기에 대한 비교 연구", Journal of Breast Cancer, 13(2), pp.187~197 (2010), 한국유방암학회
- Musaed Rayzah, "Preoperative Breast Magnetic Resonance Imaging for the Assessment of the Size of Ductal Carcinoma In Situ", Journal of Breast Disease, 4(2), pp.77~84 (2016), 한국유방암학회[DOI]
- Kang DK, "Diagnosis of the intraductal component of invasive breast cancer : assessment with mammography and sonography", J Ultrasound Med, 26, pp.1587~1600 (2007)
- Fornage BD, "Clinical, mammographic, and sonographic determination of preoperative breast cancer size", Cancer, 60, pp.765~771 (1987)